Article Details
Retrieved on: 2022-01-07 18:33:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca is stepping up its pursuit of a rare disease market targeted by Alnylam and Pfizer. Having entered the ATTR space through its takeover ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here